Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin beta 3 and TGF- beta receptor type II

Cancer patients frequently develop skeletal metastases that significantly impact quality of life. Since bone metastases remain incurable, a clearer understanding of molecular mechanisms regulating skeletal metastases is required to develop new therapeutics that block establishment of tumors in bone....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials 2015-09, Vol.64, p.33-44
Hauptverfasser: Page, Jonathan M, Merkel, Alyssa R, Ruppender, Nazanin S, Guo, Ruijing, Dadwal, Ushashi C, Cannonier, Shellese A, Basu, Sandip, Guelcher, Scott A, Sterling, Julie A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!